Literature DB >> 1312125

Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources.

H Okamoto1, Y Sugiyama, S Okada, K Kurai, Y Akahane, Y Sugai, T Tanaka, K Sato, F Tsuda, Y Miyakawa.   

Abstract

Based on variation in nucleotide sequence within restricted regions in the putative C (core) gene of hepatitis C virus (HCV), four groups of HCV have been postulated in a panel of 44 HCV isolates. They were provisionally designated types I, II, III and IV. A method for typing HCV was developed, depending on the amplification of a C gene sequence by polymerase chain reaction using a universal primer (sense) and a mixture of four type-specific primers (antisense). HCV types were determined by the size of the products specific to each of them. Type II was found in HCV samples from 131 (82%) of 159 blood donors, more often than in those from 48 (60%) of 80 patients with non-A, non-B (NANB) liver disease in Japan (P less than 0.01). In 11 haemophiliacs who had received imported coagulation factor concentrates, type I was found in five, as against type II in four. Double infection with two different HCV types was found in two patients with chronic NANB liver disease (types I and II; II and III) and two haemophiliacs (types I and II; I and III). HCV types were identical in mother and baby in each of two examples of perinatal transmission, and were also identical in donor and recipient in a case of accidental needle exposure.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1312125     DOI: 10.1099/0022-1317-73-3-673

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  219 in total

1.  Follow-up study of hepatitis C virus infection in uremic patients on maintenance hemodialysis for 30 months.

Authors:  Nian-Song Wang; Lu-Tan Liao; Yan-Juan Zhu; Wei Pan; Fang Fang
Journal:  World J Gastroenterol       Date:  2000-12       Impact factor: 5.742

2.  HCV genotypes in hepatitis C patients and their clinical significances.

Authors:  Fen Huang; Gui-Zhen Zhao; Yeng Li
Journal:  World J Gastroenterol       Date:  1999-12       Impact factor: 5.742

3.  Clinical guidelines on the management of hepatitis C.

Authors:  J C Booth; J O'Grady; J Neuberger
Journal:  Gut       Date:  2001-07       Impact factor: 23.059

4.  Interferon inhibits progression of liver fibrosis and reduces the risk of hepatocarcinogenesis in patients with chronic hepatitis C: a retrospective multicenter analysis of 652 patients.

Authors:  Mitsuhiro Takimoto; Shogo Ohkoshi; Takafumi Ichida; Yasuo Takeda; Minoru Nomoto; Hitoshi Asakura; Akira Naito; Shigeki Mori; Kojiro Hata; Kentaro Igarashi; Hidenori Hara; Hironobu Ohta; Kenji Soga; Toshiaki Watanabe; Tomoteru Kamimura
Journal:  Dig Dis Sci       Date:  2002-01       Impact factor: 3.199

5.  Hepatitis C virus genotypes in liver transplant recipients: impact on posttransplant recurrence, infections, response to interferon-alpha therapy and outcome.

Authors:  T Gayowski; N Singh; I R Marino; H Vargas; M Wagener; C Wannstedt; F Morelli; T Laskus; J J Fung; J Rakela; T E Starzl
Journal:  Transplantation       Date:  1997-08-15       Impact factor: 4.939

6.  Group specific sequences and conserved secondary structures at the 3' end of HCV genome and its implication for viral replication.

Authors:  J H Han; M Houghton
Journal:  Nucleic Acids Res       Date:  1992-07-11       Impact factor: 16.971

7.  Full-length nucleotide sequence of a Japanese hepatitis C virus isolate (HC-J1) with high homology to USA isolates.

Authors:  H Okamoto; N Kanai; S Mishiro
Journal:  Nucleic Acids Res       Date:  1992-12-11       Impact factor: 16.971

8.  Effect of in vitro interferon-beta administration on hepatitis C virus in peripheral blood mononuclear cells as a predictive marker of clinical response to interferon treatment for chronic hepatitis C.

Authors:  Kaori Mochizuki; Tatehiro Kagawa; Shinji Takashimizu; Kazuya Kawazoe; Sei-Ichiro Kojima; Naruhiko Nagata; Atsushi Nakano; Yasuhiro Nishizaki; Koichi Shiraishi; Masaru Itakura; Norihito Watanabe; Tetsuya Mine; Shohei Matsuzaki
Journal:  World J Gastroenterol       Date:  2004-03-01       Impact factor: 5.742

9.  Recent advances in laboratory diagnosis of hepatitis C virus infection.

Authors:  R Chaudhary
Journal:  Can J Infect Dis       Date:  1994-11

10.  Mapping of serotype-specific, immunodominant epitopes in the NS-4 region of hepatitis C virus (HCV): use of type-specific peptides to serologically differentiate infections with HCV types 1, 2, and 3.

Authors:  P Simmonds; K A Rose; S Graham; S W Chan; F McOmish; B C Dow; E A Follett; P L Yap; H Marsden
Journal:  J Clin Microbiol       Date:  1993-06       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.